Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 2, Pages 155
Publisher
MDPI AG
Online
2021-02-14
DOI
10.3390/ph14020155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
- (2020) Giovanni Stelitano et al. MOLECULES
- Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
- (2020) Matteo Mori et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis
- (2020) Mousumi Shyam et al. JOURNAL OF MEDICINAL CHEMISTRY
- New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
- (2019) Laurent R. Chiarelli et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis
- (2019) Matteo Mori et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation
- (2019) Eleonora Truzzi et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Oxadiazole scaffolds in anti-tuberculosis drug discovery
- (2019) Suparna S. De et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
- (2018) Laurent R. Chiarelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies
- (2018) Elena Pini et al. MOLECULES
- Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics
- (2018) Diana Machado et al. Future Microbiology
- A Review on Recent Synthetic Strategies and Pharmacological Importance of 1,3-Thiazole Derivatives
- (2018) Swarna Gowri et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Iron Acquisition in Mycobacterium tuberculosis
- (2018) Alex Chao et al. CHEMICAL REVIEWS
- Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery
- (2017) Elisa Azzali et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120
- (2017) Francesca Curreli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol
- (2017) Xiao-Kang Zhang et al. JOURNAL OF ORGANIC CHEMISTRY
- Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections
- (2017) Kaijin Xu et al. Advanced Healthcare Materials
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- Iron Acquisition Pathways as Targets for Antitubercular Drugs
- (2016) Fiorella Meneghetti et al. CURRENT MEDICINAL CHEMISTRY
- Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB): From Biological Insight to Inhibitors
- (2015) Luisa Fanzani et al. CURRENT MEDICINAL CHEMISTRY
- Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design
- (2015) Marco Pieroni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold
- (2015) Shane M. Devine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors
- (2013) Kishorkumar S. Kadam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
- (2013) Regina Wilson et al. Nature Chemical Biology
- Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis
- (2012) Timothy M. Chapman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
- (2011) D. Falzon et al. EUROPEAN RESPIRATORY JOURNAL
- Inhibitors of the Salicylate Synthase (MbtI) from Mycobacterium tuberculosis Discovered by High-Throughput Screening
- (2010) Mahalakshmi Vasan et al. ChemMedChem
- Recent advances in the design and synthesis of heterocycles as anti-tubercular agents
- (2010) Prem MS Chauhan et al. Future Medicinal Chemistry
- Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents
- (2010) B. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search